Clinical studies recruiting near Nanyang

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Peer Enriched Environment for Recovery (PEER)
NA · Nanyang Technological University · NCT07463014 Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Phase 2 · Nanshi Hospital Of Nanyang · Kunming Pharmaceuticals, Inc. · NCT07279493 A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0128 · Bristol-Myers Squibb · NCT07291076 A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Phase 1/Phase 2 · Nanyang Second General Hospital · RemeGen Co., Ltd. · NCT07105215 pBFS-guided cTBS at Different Doses for Aphasia After Stroke
NA · Nanshi Hospital of Nanyang · Changping Laboratory · NCT05969548 Clinical Studies for the Treatment of Advanced Solid Tumors
Phase 1/Phase 2 · Nanyang Second General Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06825494 Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation
NA · Fangcheng County People's Hospital · Capital Medical University · NCT07139301 Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Che
Phase 2 · The First Affiliated Hospital of Nanyang Medical College · Tianjin Medical University Cancer Institute and Hospital · NCT06141226 Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post
Phase 3 · Nanyang Central Hospital · Capital Medical University · NCT07509645 Real-world Study of Aflibercept 8 mg in nAMD
Phase N/A · Nanyang Eye Hospital · Peking University People's Hospital · NCT07640997 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · The First affiliated Hospital of Nanyang Medical College /ID · AbbVie · NCT04928846 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemo
Phase 3 · Nanyang Second General Hospital · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07385703 Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial
NA · Nanyang Central Hospital, Henan Province · The Affiliated Hospital Of Guizhou Medical University · NCT06329635 Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Phase 3 · Nanyang nanshi hospital · Capital Medical University · NCT06548971 A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary
EARLY_Phase 1 · The First Affiliated Hospital of Nanyang Medical College · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · NCT06788431 A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic
Phase 1/Phase 2 · Nanyang City Center Hospital · RemeGen Co., Ltd. · NCT06016062 A Study of YL201 Versus Investigator's Choice of Chemotherapy in Participants With Locally Advanced or Metastatic Esopha
Phase 3 · 132 · MediLink Therapeutics (Suzhou) Co., Ltd. · NCT07487896 Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
Phase 3 · Nanyang Central Hospital · Beijing InnoCare Pharma Tech Co., Ltd. · NCT06842199 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Comp
Phase 3 · Research Site · AstraZeneca · NCT07662044 Electro-Acupuncture for Obese Patients With Insulin Resistance
NA · Nanyang Technological University · NCT06609200 Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as Prophylactic Treatment.
Phase 3 · The First Affiliated Hospital of Nanyang Medical College · Hangzhou Gensciences Biopharmaceutical Co., Ltd. · NCT07684898 Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT）
Phase 3 · Nanyang Central Hospital · Capital Medical University · NCT06559241 A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors
Phase 1/Phase 2 · Nanyang Central Hospital · RemeGen Co., Ltd. · NCT06038396 ICP-332 in Subjects With Non-segmental Vitiligo
Phase 2/Phase 3 · Nanyang First People's Hospital · Beijing InnoCare Pharma Tech Co., Ltd. · NCT07047612 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 RBD5044 in Chinese Participants With Hypertriglyceridemia
Phase 2 · The First Affiliated Hospital of Nanyang Medical College · Ribotek Biopharmaceuticals (Shandong) Co., Ltd · NCT07587788 RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Smal
Phase 3 · Nanyang Second People's Hospital · RemeGen Co., Ltd. · NCT07416474 Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
NA · The First Affiliated Hospital of Nanyang Medical College · Harbin Medical University · NCT07567625 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · Investigational Site Number : 1560034 · Sanofi · NCT06241118 Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
Phase N/A · Dengzhou Central Hospital · The First Affiliated Hospital of Zhengzhou University · NCT07169656

Look up another city

Look up another condition